Singapore markets close in 2 hours 37 minutes
Straits Times Index
3,189.32 -25.75 (-0.80%) Nikkei
32,371.90 +56.85 (+0.18%) Hang Seng
17,575.17 +108.27 (+0.62%) FTSE 100
7,625.72 +1.73 (+0.02%) Bitcoin USD
26,230.69 -77.25 (-0.29%) CMC Crypto 200
561.70 -2.11 (-0.37%)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.39B |
| Enterprise value | 1.81B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 4.50 |
| Price/book (mrq) | 56.59 |
| Enterprise value/revenue | 5.90 |
| Enterprise value/EBITDA | -13.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.88 |
| 52-week change 3 | -43.07% |
| S&P500 52-week change 3 | 14.91% |
| 52-week high 3 | 14.50 |
| 52-week low 3 | 6.62 |
| 50-day moving average 3 | 7.19 |
| 200-day moving average 3 | 8.50 |
Share statistics
| Avg vol (3-month) 3 | 2.53M |
| Avg vol (10-day) 3 | 3.06M |
| Shares outstanding 5 | 189.49M |
| Implied shares outstanding 6 | 189.49M |
| Float 8 | 158.74M |
| % held by insiders 1 | 1.24% |
| % held by institutions 1 | 93.70% |
| Shares short (14 Sept 2023) 4 | 42.5M |
| Short ratio (14 Sept 2023) 4 | 18.41 |
| Short % of float (14 Sept 2023) 4 | 25.19% |
| Short % of shares outstanding (14 Sept 2023) 4 | 22.43% |
| Shares short (prior month 14 Aug 2023) 4 | 40.06M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | -79.15% |
| Operating margin (ttm) | -36.81% |
Management effectiveness
| Return on assets (ttm) | -13.56% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 306.64M |
| Revenue per share (ttm) | 1.63 |
| Quarterly revenue growth (yoy) | 25.90% |
| Gross profit (ttm) | 10.94M |
| EBITDA | -111.28M |
| Net income avi to common (ttm) | -242.72M |
| Diluted EPS (ttm) | -1.29 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 410.67M |
| Total cash per share (mrq) | 2.17 |
| Total debt (mrq) | 827.63M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 5.47 |
| Book value per share (mrq) | -2.05 |
Cash flow statement
| Operating cash flow (ttm) | -122.62M |
| Levered free cash flow (ttm) | -110.72M |
© 2023 Yahoo. All rights reserved.
